Relafen 750, recognized as naproxol, embodies a distinct example of targeted biochemical intervention within the realm of pain management . From a medicinal perspective, its mechanism of activity copyrights upon the suppression of cyclooxygenase (COX) enzymes , particularly COX-2, involved in the biosynthesis of prostaglandins . This selective acti